Nxera Pharma to Receive $100 Million Upfront and Up to $1.37 Billion in Milestones
Nxera Pharma is set to receive $100 million upfront, up to $1.37 billion in milestone payments, plus royalties.
Related stories
Autohome Q3 Revenue Fell 26% to RMB1,315.0M
Autohome reported Q3 2026 revenue of RMB1,315.0M, down from RMB1,778.1M a year earlier. Net income attributable to the company was RMB195.0M versus RMB436.6M. Its board approved an
M impact | EQUITY | Nov 04, 2026, 09:43 AM UTC
Bank Handlowy Q3 Net Profit Expected to Fall 41% Year Over Year
Bank Handlowy is expected to report a 41% year-over-year decline in third-quarter net profit. The bank is due to report on November.
M impact | EQUITY | Nov 04, 2026, 09:32 AM UTC
Persistent Systems approves allotment of 700,000 NCDs worth 70 billion rupees
M impact | EQUITY | Nov 04, 2026, 09:32 AM UTC
Ultragenyx Q3 Loss Narrows as Revenue Rises; Shares Fall Pre-Bell
M impact | EQUITY | Nov 04, 2026, 09:32 AM UTC
SITC International freight rates rise 3%
M impact | EQUITY | Nov 04, 2026, 09:32 AM UTC
HUDCO Shares Jump 6% After Strong Q2 Results
HUDCO shares gained as much as 6% on Wednesday, November 4, after September-quarter results improved across parameters year over year. Net profit grew 28.3%.
M impact | EQUITY | Nov 04, 2026, 09:32 AM UTC